CIBC World Markets’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $29M | Buy |
+236,006
| New | +$28.7M | 0.14% | 104 |
|
|
2025
Q2 | $27.2M | Sell |
245,250
-375,075
| -60% | -$39.9M | 0.17% | 92 |
|
|
2025
Q1 | $69.5M | Sell |
620,325
-40,884
| -6% | -$4.22M | 0.55% | 31 |
|
|
2024
Q4 | $61.1M | Buy |
661,209
+464,874
| +237% | +$41.9M | 0.36% | 47 |
|
|
2024
Q3 | $16.5M | Sell |
196,335
-54,393
| -22% | -$4.15M | 0.12% | 140 |
|
|
2024
Q2 | $17.2M | Buy |
250,728
+43,727
| +21% | +$2.92M | 0.11% | 130 |
|
|
2024
Q1 | $15.2M | Sell |
207,001
-246,246
| -54% | -$18.9M | 0.1% | 143 |
|
|
2023
Q4 | $36.7M | Sell |
453,247
-58,865
| -11% | -$4.58M | 0.2% | 81 |
|
|
2023
Q3 | $38.4M | Buy |
512,112
+261,479
| +104% | +$20.1M | 0.38% | 47 |
|
|
2023
Q2 | $19.3M | Buy |
250,633
+136,212
| +119% | +$10.9M | 0.16% | 106 |
|
|
2023
Q1 | $9.49M | Sell |
114,421
-233,947
| -67% | -$19.4M | 0.16% | 121 |
|
|
2022
Q4 | $29.9M | Sell |
348,368
-45,650
| -12% | -$3.62M | 0.2% | 82 |
|
|
2022
Q3 | $24.3M | Buy |
394,018
+236,543
| +150% | +$14.9M | 0.34% | 40 |
|
|
2022
Q2 | $9.73M | Sell |
157,475
-136,874
| -47% | -$8.47M | 0.09% | 142 |
|
|
2022
Q1 | $17.5M | Sell |
294,349
-50,463
| -15% | -$3.23M | 0.14% | 115 |
|
|
2021
Q4 | $25M | Buy |
344,812
+10,178
| +3% | +$701K | 0.13% | 103 |
|
|
2021
Q3 | $23.4M | Buy |
334,634
+233,964
| +232% | +$16.4M | 0.16% | 99 |
|
|
2021
Q2 | $6.93M | Sell |
100,670
-67,210
| -40% | -$4.49M | 0.05% | 209 |
|
|
2021
Q1 | $10.8M | Sell |
167,880
-1,604,361
| -91% | -$103M | 0.07% | 192 |
|
|
2020
Q4 | $103M | Buy |
1,772,241
+1,421,508
| +405% | +$85.8M | 0.52% | 38 |
|
|
2020
Q3 | $22.2M | Buy |
350,733
+146,459
| +72% | +$10.2M | 0.22% | 106 |
|
|
2020
Q2 | $15.7M | Sell |
204,274
-48,082
| -19% | -$3.68M | 0.17% | 122 |
|
|
2020
Q1 | $18.9M | Sell |
252,356
-117,089
| -32% | -$8.09M | 0.24% | 95 |
|
|
2019
Q4 | $24M | Sell |
369,445
-861,244
| -70% | -$56.1M | 0.16% | 147 |
|
|
2019
Q3 | $78M | Buy |
1,230,689
+891,043
| +262% | +$58.2M | 0.73% | 27 |
|
|
2019
Q2 | $22.9M | Buy |
339,646
+13,619
| +4% | +$896K | 0.18% | 137 |
|
|
2019
Q1 | $21.2M | Sell |
326,027
-786,398
| -71% | -$52.3M | 0.17% | 126 |
|
|
2018
Q4 | $69.6M | Buy |
1,112,425
+89,516
| +9% | +$6.26M | 0.65% | 32 |
|
|
2018
Q3 | $79M | Buy |
1,022,909
+73,082
| +8% | +$5.52M | 0.67% | 24 |
|
|
2018
Q2 | $67.3M | Buy |
949,827
+77,001
| +9% | +$5.44M | 0.58% | 36 |
|
|
2018
Q1 | $65.8M | Sell |
872,826
-344,969
| -28% | -$27.4M | 0.7% | 24 |
|
|
2017
Q4 | $87.2M | Buy |
1,217,795
+181,918
| +18% | +$13.8M | 0.63% | 34 |
|
|
2017
Q3 | $83.9M | Sell |
1,035,877
-234,378
| -18% | -$17.9M | 0.81% | 26 |
|
|
2017
Q2 | $89.9M | Sell |
1,270,255
-52,514
| -4% | -$3.49M | 0.95% | 12 |
|
|
2017
Q1 | $89.8M | Sell |
1,322,769
-239,940
| -15% | -$16.9M | 0.73% | 20 |
|
|
2016
Q4 | $112M | Buy |
1,562,709
+845,737
| +118% | +$62.9M | 1.15% | 14 |
|
|
2016
Q3 | $56.7M | Sell |
716,972
-733,753
| -51% | -$59.6M | 1.08% | 20 |
|
|
2016
Q2 | $121M | Buy |
1,450,725
+236,007
| +19% | +$20.9M | 3.14% | 6 |
|
|
2016
Q1 | $112M | Sell |
1,214,718
-310,664
| -20% | -$28M | 2.45% | 8 |
|
|
2015
Q4 | $154M | Buy |
1,525,382
+1,073,828
| +238% | +$112M | 3.14% | 6 |
|
|
2015
Q3 | $44.3M | Buy |
451,554
+209,325
| +86% | +$23.2M | 1.2% | 18 |
|
|
2015
Q2 | $28.4M | Buy |
+242,229
| New | +$26.5M | 0.9% | 30 |
|
Other funds holding GILD
CIBC World Markets's GILD Position: Q4 2025 in Review
CIBC World Markets opened a new position in Gilead Sciences (GILD) in Q4 2025: 236,006 shares worth $29M. The stake represents 0.14% of the portfolio and ranks #104 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in GILD as recently as Q2 2025.
CIBC World Markets first reported a position in GILD in Q2 2015 and has held it in 42 quarters since. The position peaked at $154M in Q4 2015. 2,216 funds tracked by Wall St. Rank hold GILD as of Q4 2025.
- CIBC World Markets held 236,006 shares of Gilead Sciences worth $29M as of Q4 2025.
- Gilead Sciences was a new CIBC World Markets position in Q4 2025.
- Gilead Sciences made up 0.14% of CIBC World Markets's portfolio in Q4 2025, its #104 holding.
- CIBC World Markets first reported a position in Gilead Sciences in Q2 2015 and has held it in 42 quarters since.
- CIBC World Markets's Gilead Sciences position peaked at $154M in Q4 2015.
- 2,216 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.
Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.